AI-generated summary
In this exploratory pilot study, the authors examined noninvasive intracranial pulse waveform measures and clinical scores in women with fibromyalgia and healthy comparators after 10 sessions of combined photobiomodulation and therapeutic ultrasound applied to the hands. The authors report that the fibromyalgia group showed fewer P2 greater than P1 waveforms, shorter time to peak, and lower pain, functional impact and sleep disturbance scores after treatment. Without a sham-treated group, the authors state these are preliminary associations rather than evidence of efficacy or causality.
- Participants
- 20
- Who or what was studied
- Women with fibromyalgia (n = 10) and healthy comparators (n = 10)
- Limits stated in the abstract
- Small exploratory pilot sample with no sham-treated control group, so findings are preliminary associations rather than evidence of treatment efficacy or causality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fibromyalgia, Photobiomodulation, Pilot study, Photobiomodulation therapy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.